Boston, Massachusetts-based Vertex Pharmaceuticals Incorporated (VRTX) develops and commercializes therapies for treating ...
Zacks Investment Research on MSN
Vertex stock down nearly 8% in 3 months: Time to buy or stay cautious?
Vertex Pharmaceuticals Incorporated VRTX stock has declined 7.9% in the past three months. One major reason for the weakness ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 15 Set-It-and-Forget-It Stocks to Buy in 2026. On March 19, 2026, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) saw its price target ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
During the last three months, 16 analysts shared their evaluations of Vertex Pharmaceuticals (NASDAQ:VRTX), revealing diverse outlooks from bullish to bearish. The following table summarizes their ...
Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) came out with its first-quarter results last week, and we wanted ...
Looking ahead to 2030, our model projects VRTX could trade at an average price of $808.82, with a potential range between $606.61 and $1,011.02. This represents a potential 81.0% return from today's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results